Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin

US Patent 11554106 · Granted Jan 17, 2023

Assignee

Inventors

View full patent text on Google Patents →